Jacqueline A H Droste

Summary

Affiliation: Radboud University Nijmegen Medical Centre
Country: The Netherlands

Publications

  1. ncbi request reprint TDM: therapeutic drug measuring or therapeutic drug monitoring?
    Jacqueline A H Droste
    Department of Clinical Pharmacy, University Medical Centre, Nijmegen, The Netherlands
    Ther Drug Monit 27:412-6. 2005
  2. ncbi request reprint Evaluation of antiretroviral drug measurements by an interlaboratory quality control program
    Jacqueline A H Droste
    Department of Clinical Pharmacy, University Medical Center, Nijmegen, The Netherlands
    J Acquir Immune Defic Syndr 32:287-91. 2003
  3. ncbi request reprint Simultaneous determination of the HIV drugs indinavir, amprenavir, saquinavir, ritonavir, lopinavir, nelfinavir, the nelfinavir hydroxymetabolite M8, and nevirapine in human plasma by reversed-phase high-performance liquid chromatography
    J A H Droste
    Deparment of Clinical Pharmacy, University Medical Center Nijmegen, Nijmegen, The Netherlands
    Ther Drug Monit 25:393-9. 2003
  4. pmc Pharmacokinetic study of tenofovir disoproxil fumarate combined with rifampin in healthy volunteers
    J A H Droste
    Department of Clinical Pharmacy, University Medical Centre Nijmegen, P O Box 9101, 533 KF, 6500 HB Nijmegen, The Netherlands
    Antimicrob Agents Chemother 49:680-4. 2005
  5. ncbi request reprint Assessment of drug-drug interactions between tenofovir disoproxil fumarate and the nonnucleoside reverse transcriptase inhibitors nevirapine and efavirenz in HIV-infected patients
    Jacqueline A H Droste
    Department of Clinical Pharmacy, Radboud University, Nijmegen Medical Centre, The Netherlands
    J Acquir Immune Defic Syndr 41:37-43. 2006
  6. doi request reprint Therapeutic drug monitoring of nevirapine in resource-limited settings
    Rafaëlla F A L'homme
    Department of Clinical Pharmacy, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    Clin Infect Dis 47:1339-44. 2008
  7. pmc Pharmacokinetics, food intake requirements and tolerability of once-daily combinations of nelfinavir and low-dose ritonavir in healthy volunteers
    R E Aarnoutse
    Department of Clinical Pharmacy, University Medical Centre Nijmegen, Nijmegen, The Netherlands
    Br J Clin Pharmacol 55:115-25. 2003
  8. ncbi request reprint Nevirapine plasma concentrations are still detectable after more than 2 weeks in the majority of women receiving single-dose nevirapine: implications for intervention studies
    Eva Muro
    Kilimanjaro Christian Medical College, Tumaini University, Moshe, Tanzania
    J Acquir Immune Defic Syndr 39:419-21. 2005
  9. ncbi request reprint False-positive results in urine drug screening in healthy volunteers participating in phase 1 studies with efavirenz and rifampin
    Charles J L la Porte
    Ther Drug Monit 28:286. 2006
  10. ncbi request reprint No virological failure in semen during properly suppressive antiretroviral therapy despite subtherapeutic local drug concentrations
    Selwyn H Lowe
    Department of Internal Medicine, Division of Infectious Diseases, Tropical Medicine and AIDS, Academic Medical Centre, University of Amsterdam, Amsterdam
    HIV Clin Trials 7:285-90. 2006

Collaborators

Detail Information

Publications11

  1. ncbi request reprint TDM: therapeutic drug measuring or therapeutic drug monitoring?
    Jacqueline A H Droste
    Department of Clinical Pharmacy, University Medical Centre, Nijmegen, The Netherlands
    Ther Drug Monit 27:412-6. 2005
    ..Almost half of the recommendations (44%) given were satisfactory. Levels of knowledge regarding HIV treatment appeared to be variable among the respondents and for this reason were partly incomparable...
  2. ncbi request reprint Evaluation of antiretroviral drug measurements by an interlaboratory quality control program
    Jacqueline A H Droste
    Department of Clinical Pharmacy, University Medical Center, Nijmegen, The Netherlands
    J Acquir Immune Defic Syndr 32:287-91. 2003
    ..This variability may have important implications for therapeutic drug monitoring of these drugs and for pharmacokinetic studies. Interlaboratory testing is useful to alert laboratories to previously undetected analytical problems...
  3. ncbi request reprint Simultaneous determination of the HIV drugs indinavir, amprenavir, saquinavir, ritonavir, lopinavir, nelfinavir, the nelfinavir hydroxymetabolite M8, and nevirapine in human plasma by reversed-phase high-performance liquid chromatography
    J A H Droste
    Deparment of Clinical Pharmacy, University Medical Center Nijmegen, Nijmegen, The Netherlands
    Ther Drug Monit 25:393-9. 2003
    ..This method proved to be simple, accurate, and precise and is useful for the therapeutic drug monitoring of protease inhibitors and the nonnucleoside reverse transcriptase inhibitor nevirapine on a routine basis...
  4. pmc Pharmacokinetic study of tenofovir disoproxil fumarate combined with rifampin in healthy volunteers
    J A H Droste
    Department of Clinical Pharmacy, University Medical Centre Nijmegen, P O Box 9101, 533 KF, 6500 HB Nijmegen, The Netherlands
    Antimicrob Agents Chemother 49:680-4. 2005
    ..In conclusion, adaptation of either the rifampin or the tenofovir DF dose for the simultaneous treatment of tuberculosis and human immunodeficiency virus (HIV) infection in HIV-infected patients is probably not required...
  5. ncbi request reprint Assessment of drug-drug interactions between tenofovir disoproxil fumarate and the nonnucleoside reverse transcriptase inhibitors nevirapine and efavirenz in HIV-infected patients
    Jacqueline A H Droste
    Department of Clinical Pharmacy, Radboud University, Nijmegen Medical Centre, The Netherlands
    J Acquir Immune Defic Syndr 41:37-43. 2006
    ..Furthermore, the combination of efavirenz 600 mg and tenofovir DF 300 mg once daily was compared with use of efavirenz 600 mg once daily only...
  6. doi request reprint Therapeutic drug monitoring of nevirapine in resource-limited settings
    Rafaëlla F A L'homme
    Department of Clinical Pharmacy, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    Clin Infect Dis 47:1339-44. 2008
    ..We developed a simple and inexpensive thin-layer chromatography (TLC) assay for semiquantitative detection of saliva concentrations of nevirapine in resource-limited settings. The method was validated in an African target population...
  7. pmc Pharmacokinetics, food intake requirements and tolerability of once-daily combinations of nelfinavir and low-dose ritonavir in healthy volunteers
    R E Aarnoutse
    Department of Clinical Pharmacy, University Medical Centre Nijmegen, Nijmegen, The Netherlands
    Br J Clin Pharmacol 55:115-25. 2003
    ..This study was performed to evaluate the steady-state pharmacokinetics, food intake requirements and short-term tolerability of once-daily combinations of nelfinavir and low-dose ritonavir...
  8. ncbi request reprint Nevirapine plasma concentrations are still detectable after more than 2 weeks in the majority of women receiving single-dose nevirapine: implications for intervention studies
    Eva Muro
    Kilimanjaro Christian Medical College, Tumaini University, Moshe, Tanzania
    J Acquir Immune Defic Syndr 39:419-21. 2005
    ..To develop intervention strategies, it is important to know the interpatient variability in nevirapine half-life in women receiving a single dose of nevirapine...
  9. ncbi request reprint False-positive results in urine drug screening in healthy volunteers participating in phase 1 studies with efavirenz and rifampin
    Charles J L la Porte
    Ther Drug Monit 28:286. 2006
  10. ncbi request reprint No virological failure in semen during properly suppressive antiretroviral therapy despite subtherapeutic local drug concentrations
    Selwyn H Lowe
    Department of Internal Medicine, Division of Infectious Diseases, Tropical Medicine and AIDS, Academic Medical Centre, University of Amsterdam, Amsterdam
    HIV Clin Trials 7:285-90. 2006
    ..The aim of the study was to investigate whether drug resistance occurs earlier in seminal than in blood plasma with the use of such HAART regimens, of which only the two NRTIs achieve therapeutic concentrations in seminal plasma...
  11. ncbi request reprint Semen quality and drug concentrations in seminal plasma of patients using a didanosine or didanosine plus tenofovir containing antiretroviral regimen
    Selwyn H Lowe
    Department of Internal Medicine, Division of Infectious Diseases, Tropical Medicine and AIDS, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Ther Drug Monit 29:566-70. 2007
    ..The authors conclude that ddI and TFV penetrate well into seminal plasma and that the reduced sperm motility deserves further study...